跳至主要内容
临床试验/NCT04500964
NCT04500964已完成不适用

Transcatheter Aortic Valve Replacement for Failed Transcatheter Aortic Valve. An International Registry

IRCCS Policlinico S. Donato1 个研究点 分布在 1 个国家目标入组 173 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
173
试验地点
1
主要终点
Overall mortality

研究概览

简要总结

Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR).

The purpouse of this study is to evaluate the indication to a second TAVR, the selection criteria of the second transcatheter aortic valve, procedural and clinical outcomes.

The primary endpoint of the study is overall mortality and Cardiovascular mortality at 1 year

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR).

排除标准

  • 未提供

结局指标

主要结局

Overall mortality

时间窗: 1 year

Overall mortality and Cardiovascular mortality at 1 year

次要结局

  • VARC-3 Events(1 year)

研究者

发起方
IRCCS Policlinico S. Donato
申办方类型
Other
责任方
Principal Investigator
主要研究者

Luca Testa

Interventional Cardiology

IRCCS Policlinico S. Donato

研究点 (1)

Loading locations...

相似试验

Transcatheter Aortic Valve Replacement for Failed... | 临床试验